Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Short Interest Update

Shionogi & Co., Ltd. (OTCMKTS:SGIOF) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 2,977,700 shares, a growth of 17.6% from the October 15th total of 2,531,500 shares. Based on an average daily volume of 1,500 shares, the short-interest ratio is presently 1,985.1 days.

Shionogi & Co., Ltd. Stock Up 6.5 %

SGIOF traded up $0.84 during midday trading on Friday, reaching $13.71. 300 shares of the company’s stock were exchanged, compared to its average volume of 2,644. The business has a 50-day simple moving average of $23.30 and a two-hundred day simple moving average of $36.33. Shionogi & Co., Ltd. has a one year low of $12.34 and a one year high of $17.83.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.